Is impulsivity a symptom of initial tobacco withdrawal? A meta-analysis and qualitative systematic review

Nicotine and Tobacco Research

Volumn 17, Issue 5, 2015, Pages 503-509

  Hughes, John R ^a   Dash, Miriam ^a   Callas, Peter W ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE LOZENGE; NICOTINE;

ABSTINENCE; CINAHL; CONTINUOUS PERFORMANCE TEST; DELAY DISCOUNTING; EXPERIMENTAL STUDY; HUMAN; IMPULSIVENESS; LIKERT SCALE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCINFO; REVIEW; SELF REPORT; SMOKING CESSATION; SYSTEMATIC REVIEW; WITHDRAWAL SYNDROME; ADULT; ADVERSE EFFECTS; FEMALE; MALE; PATHOPHYSIOLOGY; SMOKING; TIME; TOBACCO; TOBACCO DEPENDENCE;

ADULT; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; NICOTINE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO; TOBACCO USE DISORDER;

EID: 84929151918     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu220     Document Type: Review

References (44)

1. Bari A, Robbins TW. Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol. 2013;108:44-79.
2. Dick DM, Smith G, Olausson P, et al. Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol. 2010;15:217-226.
3. Mackillop J, Miller JD, Fortune E, et al. Multidimensional examination of impulsivity in relation to disordered gambling. Exp Clin Psychopharmacol. 2014;22:176-185.
4. Stevens L, Verdejo-García A, Goudriaan AE, Roeyers H, Dom G, Vanderplasschen W. Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders. J Subst Abuse Treat. 2014;47:58-72. doi:10.1016/j.jsat.2014.01.008
5. Hughes JR. Measurement of the effects of abstinence from tobacco. A qualitative review. Psychol Addict Behav. 2007;21:127-137.
6. Heishman SJ. What aspects of human performance are truly enhanced by nicotine? Addiction. 1998;93:317-320.
7. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9:315-327.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
9. World Health Organization. International Statistical Classification of Diseases and Related Problems, Tenth Revision. Geneva: World Health Organization; 1992.
10. Etter JF. A self-administered questionnaire to measure cigarette withdrawal symptoms, The Cigarette Withdrawal Scale. Nicotine Tob Res. 2005;7:47-57.
11. Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999;7:354-361.
12. West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology. 2004;177:195-199.
13. Bickel W, Jarmolowicz D, Mueller E, Koffarnus M, Gatchalian KM. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities. Pharmacol Ther. 2012;134:287-297.
14. Kelsey JE, Niraula A. Effects of acute and sub-chronic nicotine on impulsive choice in rats in a probabilistic delay-discounting task. Psychopharmacology. 2013;227:385-392.
15. Sheffer C, Christensen D, Landes R, Carter L, Jackson L, Bickel W. Delay discounting rates: a strong prognostic indicator of smoking relapse. Addict Behav. 2014;39:1682-1689.
16. Hagger MS, Wood C, Stiff C. Ego depletion and the strength model of selfcontrol: a meta-analysis. Psychol Bull. 2010;136:495-525.
17. Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B, Svensson T. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res. 1998;779:214-225.
18. Denk F, Walton M, Jennings K, Sharp T, Rushworth M, Bannerman DM. Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology. 2005;179:587-596.
19. Bickel WK, Odum A, Madden G. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology. 1999;146:447-454.
20. De wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14:22-31.
21. Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200:1-26.
22. Yoon J, Higgins S, Bradstreet M, Badger G, Thomas C. Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology. 2009;205:305-318.
23. Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction. 1994;89:1461-1470.
24. Hendricks P, Ditre J, Drobes D, Brandon T. The early time course of smoking withdrawal effects. Psychopharmacology. 2006;187:385-396.
25. de Meneses-Gaya I, Zuardi A, Loureiro S, de Souza Crippa J. Psychometric properties of the Fagerstrom Test for Nicotine Dependence. J Bras Pneumol. 2009;35:73-82.
26. Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
27. Tomko R, Solhan MB, Carpenter R, et al. Measuring impulsivity in daily life: the momentary impulsivity scale. Psychol Assess. 2014;26:334-349. doi:10.1037/a0035083
28. Hughes JR, Hatsukami DK. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289-294.
29. Hughes JR, Gust SW, Skoog K, Keenan R, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry. 1991;48:52-59.
30. Jorenby DE, Hatsukami DK, Smith SS, et al. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology. 1996;128:130-138.
31. Etter JF, Ussher M, Hughes J. A test of proposed new tobacco withdrawal symptoms. Addiction. 2013;108:50-59.
32. Heil SH, Higgins ST, Mongeon JA, Badger GJ, Bernstein IM. Characterizing nicotine withdrawal in pregnant cigarette smokers. Exp Clin Psychopharmacol. 2006;14:165-170.
33. Ussher, et al. Tobacco withdrawal symptoms and urges to smoke in pregnant versus non-pregnant smokers. Addict Behav. 2012;37:1353-1357.
34. Mitchell S. Effects of short-term nicotine deprivation on decisionmaking: delay, uncertainty and effort discounting. Nicotine Tob Res. 2004;6:819-828.
35. Field M, Santarcangelo M, Sumnall H, Goudie A, Cole J. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology. 2006;186:255-263.
36. Yi R, Johnson M, Giordano L, Landes R, Badger G, Bickel W. The effects of reduced cigarette smoking on discounting future rewards: an initial evaluation. Psychol Rec. 2008;58:163-174.
37. Yi R, Landes R. Temporal and probability discounting by cigarette smokers following acute smoking abstinence. Nicotine Tob Res. 2012;14: 547-558.
38. Harrison ELR, Coppola S, McKee SA. Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention. Exp Clin Psychopharmacol. 2009;17:91-98.
39. Kozink R, Kollins S, McClernon FJ. Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control. Neuropsychopharmacology. 2010;35:2600-2606.
40. Bradstreet MP, Higgins ST, McClernon FJ, et al. Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model. Psychopharmacology. 2014;231:2145-2158.
41. Dawkins L, Powell JH, West R, Powell J, Pickering A. A doubleblind placebo-controlled experimental study of nicotine: II-Effects on response inhibition and executive functioning. Psychopharmacology. 2007;190:457-467.
42. Dallery J, Raiff BR. Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement. Psychopharmacology. 2007;190:485-496.
43. Mongia M, Hechtman L. Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep. 2012;14:561-567.
44. Hollander E, Rosen J. Impulsivity. J Psychopharmacol. 2000;14(Supp 1):S39-S44.